Medicare Enrolled
Dr. Syed Zafar, M.D.
Hematology · Fort Myers, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Zafar from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Zafar?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Zafar
Dr. Syed Zafar is a hematology specialist in Fort Myers, FL, with 18 years of NPI registration. Based on federal Medicare data, Dr. Zafar performed 371,813 Medicare services across 5,771 unique beneficiaries.
Between the years covered by Open Payments, Dr. Zafar received a total of $79,891 from 80 pharmaceutical and/or device companies across 755 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Zafar is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 4% volume in FL
$79,891 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 116003 | Clear | January 31, 2027 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary
Medicare Utilization ↗371,813
Medicare services
Top 4% in FL for hematology
5,771
Unique beneficiaries
$16
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~20,656 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Pembrolizumab injection (Keytruda) | 71,200 | $43 | $137 |
| Anti-nausea injection (aprepitant) | 45,630 | $1 | $5 |
| Filgrastim injection (Zarxio) for white blood cells An injection of the biosimilar medication filgrastim-sndz (Zarxio) with a dosage of 1 microgram. |
40,920 | $0 | $2 |
| Nivolumab injection (Opdivo) | 27,080 | $24 | $72 |
| Oxaliplatin chemotherapy injection This procedure involves the administration of oxaliplatin, a chemotherapy medication, via injection. The dosage specified is 0.5 mg. |
24,900 | $0 | $12 |
| Daratumumab injection (Darzalex) An injection containing daratumumab and hyaluronidase-fihj administered under the skin. |
18,360 | $38 | $110 |
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
17,600 | $0 | $5 |
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
12,750 | $0 | $4 |
| Paclitaxel chemotherapy injection | 12,270 | $0 | $2 |
| Filgrastim injection, 1 microgram An injection of filgrastim, a medication that stimulates the production of white blood cells. This code specifically covers the brand-name drug and excludes biosimilar versions. |
11,100 | $1 | $3 |
| Denosumab injection (Prolia/Xgeva) | 10,740 | $19 | $51 |
| Azacitidine chemotherapy injection An injection of the medication azacitidine, measured at 1 mg per unit. |
9,200 | $0 | $4 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
8,500 | $6 | $23 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
7,370 | $0 | $3 |
| Injection, docetaxel, 1 mg | 5,866 | $0 | $7 |
| Immune globulin infusion (Gammagard) An injection of immune globulin (Gammagard Liquid) to provide antibodies. The dose specified is 500 mg. |
5,312 | $36 | $108 |
| Anti-nausea injection (Aloxi/palonosetron) | 4,640 | $1 | $28 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
3,797 | $8 | $29 |
| Bortezomib injection, 0.1 mg Administration of a 0.1 mg dose of bortezomib medication via injection. |
3,417 | $4 | $113 |
| Injection, leucovorin calcium, per 50 mg | 3,101 | $3 | $12 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
2,930 | $8 | $9 |
| Pemetrexed chemotherapy injection, 10 mg This procedure involves the administration of a 10 mg dose of pemetrexed, a chemotherapy medication, via injection. |
2,657 | $56 | $202 |
| Eflapegrastim injection, 0.1 mg An injection of eflapegrastim-xnst administered at a dose of 0.1 mg. |
2,508 | $26 | $116 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
1,917 | $2 | $7 |
| Anti-nausea injection (ondansetron/Zofran) | 1,720 | $0 | $9 |
| Injection, atropine sulfate, 0.01 mg | 1,480 | $0 | $1 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
1,456 | $12 | $61 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,453 | $100 | $339 |
| Injection, octreotide, depot form for intramuscular injection, 1 mg | 1,370 | $161 | $515 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
1,196 | $102 | $378 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
976 | $11 | $69 |
| Etoposide chemotherapy injection Administration of etoposide, a chemotherapy medication, via injection. The dose specified is 10 mg. |
932 | $1 | $18 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
819 | $67 | $239 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
667 | $2 | $41 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
428 | $22 | $84 |
| Cisplatin chemotherapy injection, 10 mg Administration of a 10 mg dose of cisplatin, a chemotherapy medication, via injection. |
420 | $2 | $13 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
392 | $50 | $189 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
383 | $2 | $7 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
378 | $10 | $42 |
| Magnesium sulfate injection, per 500 mg An injection of magnesium sulfate administered in 500 mg increments. |
308 | $1 | $2 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
302 | $1 | $3 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
299 | $1 | $6 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
278 | $25 | $156 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
258 | $51 | $178 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
257 | $22 | $79 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
243 | $7 | $69 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
230 | $58 | $206 |
| IV chemotherapy initiation with community continuation Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living. |
230 | $133 | $637 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
207 | $16 | $56 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
178 | $17 | $59 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 137 | $132 | $562 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
127 | $26 | $89 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
118 | $16 | $56 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
102 | $131 | $453 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
98 | $45 | $170 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
93 | $1 | $7 |
| Intravenous chemotherapy injection Chemotherapy medication is administered directly into a vein using a push technique. This method involves injecting the drug through a needle or catheter already placed in the vein. |
82 | $81 | $303 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
79 | $30 | $156 |
| Automated red blood cell count An automated laboratory test that measures the number of red blood cells in a blood sample. |
71 | $4 | $10 |
| New patient office visit, complex (60-74 min) | 68 | $169 | $585 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
63 | $2 | $8 |
| Methylprednisolone injection, up to 40 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, administered in a dose of up to 40 mg. |
59 | $3 | $11 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
44 | $65 | $192 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
32 | $143 | $474 |
| Automated red blood cell count with calculations A blood test that automatically counts red blood cells and performs additional calculations to assess blood health. |
15 | $5 | $20 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
5.8% high complexity
91.5% medium
2.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$79,891
Total received (2018-2024)
Avg $11,413/year across 7 years
Top 7% in FL for hematology
80
Companies
755
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$57,256 (71.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,893 (16.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$9,742 (12.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$8,592
2023
$9,428
2022
$21,599
2021
$2,721
2020
$2,878
2019
$20,534
2018
$14,140
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$13,849
Seagen Inc.
$8,714
Janssen Biotech, Inc.
$6,019
E.R. Squibb & Sons, L.L.C.
$5,219
GlaxoSmithKline, LLC.
$4,901
BeiGene USA, Inc.
$4,063
Verastem, Inc.
$3,572
Bayer HealthCare Pharmaceuticals Inc.
$3,480
Celgene Corporation
$3,349
Seattle Genetics, Inc.
$3,061
Karyopharm Therapeutics Inc.
$2,460
NOVARTIS PHARMACEUTICALS CORPORATION
$2,160
Merck Sharp & Dohme LLC
$2,124
Taiho Oncology, Inc.
$1,987
TAIHO ONCOLOGY, INC.
$1,934
MorphoSys, US Inc.
$1,845
BeiGene, Ltd.
$1,512
Novartis Pharmaceuticals Corporation
$988
Bayer Healthcare Pharmaceuticals Inc.
$866
Merck Sharp & Dohme Corporation
$768
PFIZER INC.
$754
ABBVIE INC.
$680
Epizyme, Inc.,
$549
Incyte Corporation
$509
Genentech USA, Inc.
$483
Gilead Sciences, Inc.
$256
Agios Pharmaceuticals, Inc.
$207
Daiichi Sankyo Inc.
$191
Takeda Pharmaceuticals U.S.A., Inc.
$190
Lilly USA, LLC
$187
Adaptive Biotechnologies Corporation
$182
Spectrum Pharmaceuticals Inc.
$179
Exelixis Inc.
$175
GENZYME CORPORATION
$171
Amgen Inc.
$157
NanoString Technologies, Inc.
$125
Regeneron Healthcare Solutions, Inc.
$122
Janssen Pharmaceuticals, Inc
$116
MENARINI SILICON BIOSYSTEMS, INC.
$115
Deciphera Pharmaceuticals Inc.
$109
JAZZ PHARMACEUTICALS INC.
$101
Intuitive Surgical, Inc.
$96
Eisai Inc.
$95
ACELL, INC.
$94
Ipsen Biopharmaceuticals, Inc
$93
Pharmacyclics LLC, An AbbVie Company
$86
Array BioPharma Inc.
$85
ARRAY BIOPHARMA INC
$85
Astellas Pharma US Inc
$74
Intera Oncology, Inc
$69
EMD Serono, Inc.
$57
AbbVie, Inc.
$53
EUSA Pharma (US) LLC
$48
Rigel Pharmaceuticals, Inc.
$40
CSL Behring
$38
AbbVie Inc.
$35
Alnylam Pharmaceuticals Inc.
$30
Dendreon Pharmaceuticals LLC
$25
GE HEALTHCARE
$25
Dexcom, Inc.
$24
PharmaEssentia USA Corporation
$23
Clovis Oncology, Inc.
$23
Pharmacyclics LLC, an AbbVie Company
$23
Immunomedics, Inc.
$22
Kite Pharma, Inc.
$20
Sirtex Medical Inc
$19
TESARO, Inc.
$18
TerSera Therapeutics LLC
$17
SOBI, INC
$17
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$17
CTI BioPharma Corp.
$15
Helsinn Therapeutics (U.S.), Inc.
$13
Global Blood Therapeutics, Inc.
$13
Sun Pharmaceutical Industries Inc.
$13
Boehringer Ingelheim Pharmaceuticals, Inc.
$13
EISAI INC.
$12
ADC Therapeutics America, Inc.
$12
Secura Bio, Inc.
$11
Fortovia Therapeutics, Inc.
$5
Veracyte, Inc.
$4
Top 3 companies account for 35.8% of total payments
Associated products mentioned in payments ›
6 · ADAKVEO · ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · Abraxane · Alecensa · Aliqopa · Avastin · BESREMI · BEVESPI AEROSPHERE · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Braftovi · CABOMETYX · CALQUENCE · CAR-T · CEREZYME · CYRAMZA · Cabometyx · Cellsearch · Copiktra · Creon · DARZALEX · Da Vinci Surgical System · Dexcom G6 Transmitter · Doptelet · ELIQUIS · ELITEK · EMPLICITI · ENHERTU · EPKINLY · ERLEADA · Enhertu · Erleada · FARXIGA · FRUZAQLA · Farydak · GAUCHER-DISEASE · GAZYVA · GILOTRIF · IBRANCE · IDHIFA · IMBRUVICA · IMFINZI · INFLECTRA · INJECTAFER · INLYTA · INTERA · INVOKANA · Idelvion · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · Kyprolis · LENVIMA · LIBTAYO · LONSURF · LORBRENA · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MVASI · MYLOTARG · NINLARO · Neulasta · Nplate · OJJAARA · ONPATTRO · ONUREG · OPDIVO · OPDUALAG · OXBRYTA · Onivyde · PADCEV · PIQRAY · PROMACTA · PROSIGNA ASSAY · PROVENGE · Perjeta · Phesgo · Pomalyst · Prolia · QINLOCK · REBLOZYL · ROLVEDON · RYBREVANT · Revlimid · Rubraca · SANDOSTATIN · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SPRYCEL · SUTENT · Stivarga · Sylvant · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TEVIMBRA · TIBSOVO · TUKYSA · Tavalisse · Tecentriq · Trodelvy · VENCLEXTA · VERZENIO · VOTRIENT · VYXEOS · Venclexta · Vitrakvi · Vonjo · Vyloy · XALKORI · XARELTO · XGEVA · XIFAXAN · XPOVIO · XTANDI · Xospata · Xtandi · YONSA · ZEJULA · ZEPZELCA · ZOLADEX · ZYTIGA · Zevalin · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (72%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 7% for hematology in FL.
Equivalent to $21 per 100 Medicare services performed
Geographic Context
Hematologists within 10 mi
15
Per 100K population
1.9
County median income
$73,099
Nearest hospital
PARK ROYAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Zafar is a mixed practice specialist, with above-average Medicare volume (top 4% in FL), with consulting-driven industry engagement in the top 7% of FL peers, with 18 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Zafar experienced with pembrolizumab injection (keytruda)?
Based on Medicare claims data, Dr. Zafar performed 71,200 pembrolizumab injection (keytruda) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Zafar receive payments from pharmaceutical companies?
Yes. Dr. Zafar received a total of $79,891 from 80 companies across 755 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Zafar's costs compare to other hematologists in Fort Myers?
Dr. Zafar's average Medicare payment per service is $16. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Zafar) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologists in Fort Myers
Browse hematologists in Fort Myers ranked by procedure volume and transparency data.
Highest volume
Top Hematologists in FL
Hematologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologists in FL
Which FL hematologists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Seagen Inc. Payments to Doctors
See all physicians who received payments from Seagen Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology